Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
In the coming years, atrial fibrillation (AF) patients will increasingly have more choice for anticoagulation therapy. Although Boehringer Ingelheim’s Pradaxa (dabigatran etexilate) and emerging facto…
The market for asthma and chronic obstructive pulmonary disease (COPD) has grown notably in recent years because of increasing prevalence and diagnosis rates for both conditions as well as the greater…
According to the National Institute of Mental Health, each year tens of millions of Americans are affected by mental illness. Although significant strides have been made toward understanding the patho…
Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
Regional Intelligence Briefings are semi-annual Webinar-based presentations from HealthLeaders-InterStudy analysts. The presentations focus on commercial, provider, care management and healthcare refo…
According to the American Liver Foundation, 4 million Americans, or 1.8% of the population, are or have been infected with the hepatitis C virus. Approximately 70% of infected persons will develop a c…
HealthLeaders-InterStudy periodically publishes special analyst reports on healthcare topics of interest.
With increased diagnosis rates and higher drug prices for multiple sclerosis (MS), U.S. health plans have grown more focused on their coverage of and spending on MS therapies. Partly because of the pr…
The significant impact of cardiovascular disease on human morbidity and mortality alongside the proven efficacy of many lipid-modifying therapies drives both the aggressive treatment of dyslipidemia b…
HealthLeaders-InterStudy has prepared an executive brief on Top Managed Care Trends for 2011.
Private and Medicare plans will continue their receptiveness to oral oncology therapies over the next five years, but anticipated increases in coinsurance rates and copays will shift more of the cost…